Apply to Present at BIO CEO & Investor Conference
Tuesday, December 1, 2015
The annual BIO CEO & Investor Conference being held in New York City on February 8-9, 2016 is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because the mission is to support industry-wide success, a broad and unbiased view of investment opportunities is presented.
The conference will bring together a select group of established public biotech companies, a select group of late-stage private companies, and investors to foster the development of important new medicines that will expand the industry’s pipeline. Public company presentations are 25 minutes in length, while Private Company presentations are 13 minutes in length, and will be reserved specifically for established private companies (past Series B round and >$25M raised to date).
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics or platform technologies. Service providers will not be considered. Please note, there are registration and presentation fees associated with presenting. All final qualifications are determined by BIO.
Visit the conference Registration Page for more information and apply to present if meeting the stated criteria.